Keywords: ucb, pharma, levetiracetam, phase, iii, data, show

UCB Pharma's levetiracetam, Phase III data show efficacy in epilepsy

Article | 14 September 1999

Print This

UCB Pharma's levetiracetam has been shown to be effective in thetreatment of partial and secondary generalized epilepsy, according to Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in